These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10517352)

  • 1. Reversed-phase high-performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients.
    Xu G; Di Stefano C; Liebich HM; Zhang Y; Lu P
    J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):307-13. PubMed ID: 10517352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
    Xu G; Schmid HR; Lu X; Liebich HM; Lu P
    Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
    Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
    Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of urinary nucleosides by high-performance liquid chromatography.
    Liebich HM; Di Stefano C; Wixforth A; Schmid HR
    J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and identification of urinary nucleosides. Applications of high-performance liquid chromatographic methods to the synthesis of 5'-deoxyxanthosine and the simultaneous determination of 5,6-dihydrouridine and pseudouridine.
    Nakano K; Yasaka T; Schram KH; Reimer ML; McClure TD; Nakao T; Yamamoto H
    J Chromatogr; 1990 Aug; 515():537-46. PubMed ID: 2283377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversed-phase high-performance liquid chromatographic investigation of mucosal nucleosides and bases and urinary modified nucleosides of gastrointestinal cancer patients.
    Nakano K; Shindo K; Yasaka T; Yamamoto H
    J Chromatogr; 1985 Sep; 343(1):21-33. PubMed ID: 4066857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of urinary nucleosides excretion of intestinal cancer patients by reversed-phase high performance liquid chromatography].
    Zheng YF; Chen YJ; Pang T; Shi XZ; Kong HW; Lü S; Yang Q; Xu GW
    Se Pu; 2002 Nov; 20(6):498-501. PubMed ID: 12682995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides.
    Seidel P; Seidel A; Herbarth O
    Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography.
    Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE.
    Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H
    Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of high performance liquid chromatographic method using monolithic column for the determination of urinary nucleosides].
    Zhao X; Zheng Y; Zhang P; Kong H; Xu G
    Se Pu; 2005 Jan; 23(1):73-5. PubMed ID: 15881371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer.
    Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations.
    Seidel A; Seidel P; Manuwald O; Herbarth O
    Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified nucleosides in body fluids of tumor-bearing patients.
    Salvatore F; Colonna A; Costanzo F; Russo T; Esposito F; Cimino F
    Recent Results Cancer Res; 1983; 84():360-77. PubMed ID: 6844698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers.
    Liebich HM; Müller-Hagedorn S; Klaus F; Meziane K; Kim KR; Frickenschmidt A; Kammerer B
    J Chromatogr A; 2005 Apr; 1071(1-2):271-5. PubMed ID: 15865203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of urinary excretion of modified nucleosides.
    Gehrke CW; Kuo KC; Waalkes TP; Borek E
    Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary nucleosides.
    Schram KH
    Mass Spectrom Rev; 1998; 17(3):131-251. PubMed ID: 10095827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of normal and modified nucleosides in urine samples by high-performance liquid chromatography with different stationary phases.
    Studzińska S; Buszewski B
    Biomed Chromatogr; 2014 Aug; 28(8):1140-6. PubMed ID: 24453057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
    Struck-Lewicka W; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.